Ligand Pharmaceuticals Inc
XBER:LGDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Ligand Pharmaceuticals Inc
XBER:LGDN
|
US |
|
Grifols SA
LSE:0RDV
|
ES |
|
N
|
Naturgy Energy Group SA
SWB:GAN
|
ES |
|
Carter's Inc
NYSE:CRI
|
US |
|
Industrie De Nora SpA
LSE:0ABI
|
IT |
|
Haitong Securities Co Ltd
OTC:HAITY
|
CN |
|
Hon Hai Precision Industry Co Ltd
TWSE:2317
|
TW |
|
F
|
Fortescue Metals Group Ltd
F:FVJ
|
AU |
|
KLX Energy Services Holdings Inc
F:KX4A
|
US |
|
C
|
Compagnie Generale des Etablissements Michelin SCA
F:MCH
|
FR |
|
S
|
Societe Generale SA
OTC:SCGLF
|
FR |
|
Globe Life Inc
NYSE:GL
|
US |
|
Arm Holdings PLC
NASDAQ:ARM
|
UK |
|
Mobilezone Holding AG
F:TGE1
|
CH |
|
C
|
China Minsheng Banking Corp Ltd
HKEX:1988
|
CN |
Bankruptcy Probability
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ligand Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
4.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ligand Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ligand Pharmaceuticals Inc has total debt of 446.2m USD. This includes both short-term (0 USD) and long-term (446.2m USD) debt.
You can find a full breakdown on its Balance Sheet.
